Radicle GI HealthTM VNB: A Study Assessing the Impact of Health and Wellness Products on Constipation and Related Health Outcomes
Part of paid clinical trials in Del Mar, California.
- Sponsor
- Radicle Science
- Study ID
- NCT07713810
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Constipation
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 105 Years
- Healthy Volunteers
- Accepted
Interventions
- Placebo GI Health Control — DIETARY_SUPPLEMENTParticipants will use their Placebo GI Health Control product as directed for a period of 4 weeks
- Active GI Health Product — DIETARY_SUPPLEMENTParticipants will use their Active GI Health Product as directed for a period of 4 weeks
Study Details
Radicle GI HealthTM VNB: A randomized, double-blind, placebo- controlled direct-to-consumer study assessing the impact of health and wellness products on constipation and related health outcomes
Key Dates
- First listed
- Jul 20, 2026
- Start date
- Jul 16, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 16, 2027
- Completion
- Jul 16, 2027
Study Design
- Enrollment
- 550 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Active GI Health Product 1Active GI Health Product 1
- Placebo Comparator: Placebo GI Health ControlPlacebo GI Health Control
Primary Outcome Measure
Change in Constipation [ Time Frame: 5 weeks ]
Central Contacts
- Study Manager858-779-0086
- Susan Hewlings760-281-3898
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Radicle Science Inc. | Del Mar | California | 92014-2605 | Megan Moseley |
Find similar trials in Del Mar, CA
By research site
Related Studies
- Fecobionics in Biofeedback Therapy in Dyssynergia PatientsRecruiting · The California Medical Innovations Institute, Inc. · San Diego, California
- A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)PHASE2 · Recruiting · Eli Lilly and Company · Mesa, Arizona
- Understanding Mechanisms of Normal and Disordered DefecationRecruiting · Mayo Clinic · Rochester, Minnesota
- Indiana University Gastrointestinal Motility Diagnosis RegistryRecruiting · Indiana University · Indianapolis, Indiana